Skip to main content
. 2017 Jul 31;97(4):1062–1069. doi: 10.4269/ajtmh.17-0221

Table 4.

Characteristic features associated with different DENV serotypes, Nepal

DENV-1 (N = 58) DENV-2 (N = 25) DENV-3 (N = 2) DENV-4 (N = 5) P value
Age in years, median (IQR) 29.0 (17.8–40.0) 28.0 (15.5–36.0) ND 25.0 (20.0–37.5) 0.696
Age group (years) ≤ 15 9 (15.5) 6, 24.0 0 0 0.489
> 15 49 (84.5) 19 (76.0) 2 (100.0) 5 (100.0)
DOI median (IQR)* 3.0 (2.0–4.0) 4.0 (3.0–5.0) ND 6.0 (4.0–6.0) 0.01
Sex Male 41 (70.7) 15 (60.0) 2 (100.0) 3 (60.0) 0.571
Outbreak site Western 7 (12.1) 15 (60.0) 0 0 < 0.001
Central 51 (87.9) 10 (40.0) 2 (100.0) 5 (100.0)
Immune response Primary 38 (65.5) 7 (28.0) 2 (100.0) 1 (20.0) 0.014
Secondary 20 (34.5) 18 (72.0) 0 4 (80.0)
Disease spectrum DF 52 (89.7) 16 (64.0) 2 (100.0) 5 (100.0) 0.01
DHF/DSS 6 (10.3) 9 (36.0) 0 0

DENV = dengue virus; DF = dengue fever; DHF = dengue hemorrhagic fever; DOI = days postonset of illness; DSS = dengue shock syndrome; IQR = interquartile range; ND = not done. P value was calculated for age and DOI by Kruskal–Wallis test in three groups (DENV-1, -2, and -4).

*

DOI difference between two groups was estimated by Mann–Whitney U test for DENV-1 vs. -2 (P = 0.023), DENV-1 vs. -4 (P = 0.007) and DENV-2 vs. -4 (P = 0.112). For categorical variables, difference was calculated using χ2 test. DENV-3 was not included in the statistical analysis due to small sample size (N = 2). Figures in the parenthesis indicate percentages unless otherwise indicated.

Secondary infection was more common with DENV-2 compared with DENV-1 (P = 0.002).